✦ LIBER ✦

PMS48 Intravenously Administered Golimumab Significantly Improves Health Related Quality of Life and Work Productivity in Patients with Rheumatoid Arthritis: Results of a Phase III, Placebo-Controlled Trial

✍ Scribed by R. Westhovens; M.E. Weinblatt; C. Han; T. Gathany; L. Kim; M. Mack; J. Lu; D. Baker; A. Mendelsohn; C. Bingham

Book ID: 119311180
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 60 KB
Volume: 15
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2012.03.237

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adalimumab improves health-related quali

Adalimumab improves health-related quality of life and work productivity in patients with hidradenitis suppurativa: Results from a placebo-controlled phase II trial

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Milnacipran improves health-related qual

Milnacipran improves health-related quality of life in patients with fibromyalgia (FM): results from a pivotal phase III randomized controlled trial

✍ R. Gendreau; D. Clauw; D. Williams; V. Strand; R. Palmer 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Function and health-related quality of l

Function and health-related quality of life: Results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis

✍ Vibeke Strand; Peter Tugwell; Claire Bombardier; Andreas Maetzel; Bruce Crawford 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB 👁 2 views

PMS66 EARLY AND SUSTAINED REMISSION ASSO

PMS66 EARLY AND SUSTAINED REMISSION ASSOCIATED WITH NORMALIZED PHYSICAL FUNCTION AND HEALTH-RELATED QUALITY OF LIFE AND SIGNIFICANTLY IMPROVED PRODUCTIVITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH GOLIMUMAB: TWO YEAR DATA FROM THE PHASE III GO-REVEAL CLINICAL TRIAL

✍ A. Kavanaugh; I. McInnes; G.G. Krueger; D. Gladman; A. Beutler; T. Gathany; S. M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Ustekinumab significantly improves sympt

Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial

✍ Richard G. Langley; Steven R. Feldman; Chenglong Han; Brad Schenkel; Philippe Sz 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 415 KB

Golimumab, a new human anti–tumor necros

Golimumab, a new human anti–tumor necrosis factor α antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight–week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study

✍ Joel Kremer; Christopher Ritchlin; Alan Mendelsohn; Daniel Baker; Lilianne Kim; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB 👁 1 views